ST九有(600462.SH):終止收購和合診斷不低於51%股權事項 明起復牌
格隆匯8月2日丨ST九有(600462.SH)公佈,此前披露,公司擬通過發行股份及支付現金的方式購買李瑋、劉志剛等所持有的北京和合醫學診斷技術股份有限公司(“和合診斷”)不低於51%的股權,同時以非公開發行股份方式募集配套資金。公司因籌劃發行股份購買資產並募集配套資金事項,公司股票自2021年7月20日開市起停牌。
停牌期間,公司組織相關各方積極推進此次重大資產重組工作。由於標的資產股東人數眾多,股權結構分散,股東各自利益訴求不一等原因,公司經過多次努力,直至最後時限仍未能與個別交易對方就重要交易條款達成一致意見。
公司審慎研究後,決定終止籌劃該次發行股份購買資產並募集配套資金事項,公司股票將於2021年8月3日(星期二)開市起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.